What is Prime Medicine's total equity?

Prime Medicine (PRME) reported total equity of $76.7M in Q1 2026.

How has Prime Medicine's total equity changed year-over-year?

Prime Medicine's total equity decreased by 28.3% year-over-year, from $106.92M to $76.7M.

What is the long-term trend for Prime Medicine's total equity?

Over 5 years (2020 to 2025), Prime Medicine's total equity has grown at a 120.1% compound annual growth rate (CAGR), from $2.34M to $120.87M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Prime Medicine PRME Total Equity

Total Equity at other companies

Eli LillyLLY

$31.2B+97.9%

Vertex PharmaceuticalsVRTX

$19.36B+17.4%

Intellia TherapeuticsNTLA

$620.94M-20.4%

CRISPR TherapeuticsCRSP

$1.81B-0.8%

Beam TherapeuticsBEAM

$1.16B+3.1%

RegenxbioRGNX

$21.08M-92.3%

Other financials

Income statement

See full

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

See full

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total assets$294.7M-10.2%

Cash flow

See full

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

See full

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

See full

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

See full

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prime Medicine's total equity?: Prime Medicine (PRME) reported total equity of $76.7M in Q1 2026.
How has Prime Medicine's total equity changed year-over-year?: Prime Medicine's total equity decreased by 28.3% year-over-year, from $106.92M to $76.7M.
What is the long-term trend for Prime Medicine's total equity?: Over 5 years (2020 to 2025), Prime Medicine's total equity has grown at a 120.1% compound annual growth rate (CAGR), from $2.34M to $120.87M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.